Does BEXAROTENE Cause Dyslipidaemia? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Dyslipidaemia have been filed in association with BEXAROTENE (Bexarotene). This represents 2.5% of all adverse event reports for BEXAROTENE.
19
Reports of Dyslipidaemia with BEXAROTENE
2.5%
of all BEXAROTENE reports
3
Deaths
6
Hospitalizations
How Dangerous Is Dyslipidaemia From BEXAROTENE?
Of the 19 reports, 3 (15.8%) resulted in death, 6 (31.6%) required hospitalization, and 3 (15.8%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEXAROTENE. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does BEXAROTENE Cause?
Drug ineffective (67)
Hypothyroidism (65)
Death (53)
Hypertriglyceridaemia (44)
Off label use (32)
Disease progression (28)
Blood cholesterol increased (27)
Malignant neoplasm progression (26)
Pruritus (24)
Nausea (22)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which BEXAROTENE Alternatives Have Lower Dyslipidaemia Risk?
BEXAROTENE vs BEZAFIBRATE
BEXAROTENE vs BEZLOTOXUMAB
BEXAROTENE vs BGB-11417
BEXAROTENE vs BICALUTAMIDE
BEXAROTENE vs BICTEGRAVIR